Recurrent monomorphic epitheliotropic intestinal T-cell lymphoma with aberrant CD20 expression: An implication for anti-CD20 (rituximab) antibody therapy?
Pi-Han LiaoShih-Cheng ChouWan-Ting HuangYing-Zhen SuMing-Chung WangShih-Sung ChuangPublished in: Pathology international (2018)